newsfilter
← Latest News
GlobeNewswire·

AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer

LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today that it is